Topic: Sars Vaccine

Dr. Peter Hotez discusses his own experience with a Paxlovid rebound infection, noting that Dr. Anthony Fauci experienced the same. Hotez suggests extending the treatment course to ten days to fully eradicate the virus. The segment also highlights Hotez's past involvement in chimeric coronavirus research and his warnings about potential laboratory releases of SARS-related viruses.

Operation Warp Speed is presented as a "wonderful" scientific advance, though skeptics question the speed and safety. A parody of "Grandma Got Run Over by a Reindeer" tells the story of a grandmother dying after a Christmas visit and being shamed at her funeral. The discussion notes that half of Americans remain hesitant or unwilling to get vaccinated, complicating the "end" of the pandemic.

Robert F. Kennedy Jr. details the history of failed coronavirus vaccine development, specifically citing 2012 trials where ferrets developed robust antibodies but died upon exposure to the wild virus. This phenomenon, known as pathogenic priming or antibody-dependent enhancement (ADE), was previously observed in 1960s RSV trials and a Dengue vaccine rollout in the Philippines. Kennedy criticizes Dr. Anthony Fauci for allowing current manufacturers to bypass traditional animal testing protocols.

Scientist Stephen Mosier argues that a single effective vaccine is unlikely due to the many mutations of the virus. He claims that 11 different strains have been identified and suggests the virus's instability mirrors the common cold, for which no vaccine exists.

South Korea recently re-closed hundreds of schools following a spike in COVID-19 cases linked to a distribution center. Meanwhile, doctors in Italy report that the coronavirus may be losing potency, which could complicate vaccine development. The hosts compare the situation to the original SARS outbreak and discuss the planned reopening of the Louvre Museum in Paris with social distancing measures.

The hosts question the viability of a coronavirus vaccine, noting that no successful vaccine was ever developed for MERS or SARS. They discuss the theory that the virus may naturally degenerate or "turn into dust" before a vaccine can be brought to market. This uncertainty contrasts with the high-speed "Operation Warp Speed" efforts currently underway.